XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss, net
(Accumulated Deficit) Retained Earnings
Noncontrolling Interest in Subsidiary
Beginning balance (in shares) at Dec. 31, 2020   36,177        
Beginning balance at Dec. 31, 2020 $ 154,909 $ 4 $ 310,388 $ (1,280) $ (154,737) $ 534
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted stock (in shares)   318        
Vesting of restricted stock (2,026)   (2,026)      
Equity compensation 1,349   1,349      
Foreign currency translation adjustment, net of taxes (6)     (6)    
Consolidated net income 19,448       19,448  
Ending balance (in shares) at Mar. 31, 2021   36,495        
Ending balance at Mar. 31, 2021 173,674 $ 4 309,711 (1,286) (135,289) 534
Beginning balance (in shares) at Dec. 31, 2021   37,024        
Beginning balance at Dec. 31, 2021 297,528 $ 4 321,552 (1,293) (22,735) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted stock (in shares)   419        
Vesting of restricted stock (5,028)   (5,028)      
Equity compensation 1,601   1,601      
Foreign currency translation adjustment, net of taxes (11)     (11)    
Consolidated net income 61,983       61,983  
Ending balance (in shares) at Mar. 31, 2022   37,443        
Ending balance at Mar. 31, 2022 $ 356,073 $ 4 $ 318,125 $ (1,304) $ 39,248 $ 0